Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies

International Journal of Cancer

Volumn 126, Issue 8, 2010, Pages 1992-1996

  De Martel, Catherine ^a   Plummer, Martyn ^a   Van Doom, Leen Jan ^b   Vivas, Jorge ^c   Lopez, Gladys ^c   Carillo, Elsa ^c   Peraza, Simon ^c   Muñoz, Nubia ^d   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b DDL DIAGNOSTIC LABORATORY   (Netherlands)

^c Cancer Control Center of Tachlra State   (Venezuela)

^d INSTITUTO NACIONAL DE CANCEROLOGIA   (Colombia)

Author keywords

Diagnosis; Gastric biopsy; Helicobacter pylori; Polymerase chain reaction

Indexed keywords

EOSIN; HEMATOXYLIN; VACUOLATING TOXIN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM DETECTION; CANCER DIAGNOSIS; CHRONIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENTEROPATHY; FEMALE; GIEMSA STAIN; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTESTINE DYSPLASIA; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; BIOPSY; COMPARATIVE STUDY; CYTOCHEMISTRY; GENETICS; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR;

ADULT; AGED; BIOPSY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 77949895575     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/jic.2498     Document Type: Article

References (21)

1. 1, Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000;92: 1881-1888 (Pubitemid 32036918)
2. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53:1244-1249
3. 3. Ley C, Mohar A, Guarner J, HerreraGoepfert R, Figueroa LS, Halperin D, Johnstone I, Parsonnet J, Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 2004;13:4-10. (Pubitemid 38116614)
4. 4, Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. 7AMA 2004;291:187-194 (Pubitemid 38082812)
5. 5, You WC, Brown LM., Zhang L, Li JY, Jin. ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-983 (Pubitemid 44288162)
6. 6, Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007;20: 280-322. (Pubitemid 46709306)
7. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System, International Workshop on the Hlstopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
8. el-Zimaity HM, Graham DY, al-Assi MT, Malaty H, Karttunen TJ, Graham DP, Huberman RM, Genta RM. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27:35-41.
9. 9. Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, Lee HS, Choe C, Lee DH, Jung HC, Song IS. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol 2007;41: 751-755 (Pubitemid 47267761)
10. Iftner T, Villa LL. Chapter 12: human papillomavirus technologies. J Natl Cancer Inst Monogr 2003;80-88
11. 11. Plummer M., van Doom LJ, Franceschi S, Kleter B, Canzian F, Vivas J, Lopez G, Colin D, Muñoz N, Kato I. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions, / Natl Cancer Inst 2007;99:1328-1334 (Pubitemid 47394171)
12. Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, Cano E, Castro D, Andrade O, Sanchez V, Garcia R, Buiatti E, et aLChemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population, J Natl Cancer Inst 2007;99:137-146
13. 13. Muñoz N, Kato I, Peraza S, Lopez G, Carrillo E, Ramirez H, Vivas J, Castro D, Sanchez V, Andrade O, Buiatti E, Oliver W. Prevalence of precancerous lesions of the stomach in Venezuela, Cancer Epidemiol Biomarkers Prev 1996;5:41-46 (Pubitemid 26020542)
14. Filipe MI, Jass JR. Intestinal metaplasia subtypes and cancer risks. Edinburgh: Churchill Livingston, 1986. 87-89
15. 15, van Doom LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Ng EK, Atherton JC, Blaser MJ, Quint WG. Expanding allelic diversity of Helicobacter pylori vacA. ] Clin Microbiol 1998;36:2597-2603 (Pubitemid 28380962)
16. 16, van Doom LJ, Figueiredo C, Rossau R, Jannes G, van Asbroek M, Sousa JC, Carneiro F, Quint WG, Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. JClin Microbiol 1998;36: 1271-1276 (Pubitemid 28208012)
17. 17. van Doom LJ, Henskens Y, Nouhan N, Verschuuren A, Vreede R, Herbink P, Ponjee G, van Krimpen K, BIankenburg R, Scherpenisse J, Quint W. The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. 7 Clin Microbiol 2000; 38:1.3-7, (Pubitemid 30043256)
18. Christensen AH, Gjorup T, Hilden J, Fenger C, Henriksen B, Vyberg M, Ostergaard K, Hansen BF. Observer homogeneity in the histologic diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient, and repeat frequency, Scand J Gastroenterol 1992;27:933-939
19. 19. Bayerdorffer E, Oertel H, Lehn N, Kasper G, Mannes GA, Sauerbruch T, Stolte M. Topographie association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989;42: 834-839 (Pubitemid 19190754)
20. 20. Quintero E, Pizarro MA, Rodrigo L, Pique JM, Lanas A, Ponce J, Mino G, Gisbert J, Jurado A, Herrero MJ, Jimenez A, Torrado J, et al. Association of Helicobacter pylorirelated distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 2005;10:12-21. (Pubitemid 40269369)
21. Rocha GA, Guerra JB, Rocha AM, Saraiva IE, da Silva DA, de Oliveira CA, Queiroz DM. ILlRN polymorphic gene and cagApositive status independently increase the risk of noncardia gastric carcinoma. Int J Cancer 2005;115:678-683